Meeting At-Risk Criteria Increases Risk for Transition to Bipolar Disorder
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Sept. 20, 2023 -- Patients meeting bipolar at-risk (BAR) criteria are significantly more likely to transition to bipolar disorder (BD) during the next decade versus patients seeking mental health care not meeting the BAR criteria, according to a study published online Sept. 15 in JAMA Network Open.
Aswin Ratheesh, M.D., Ph.D., from Orygen in Parkville, Australia, and colleagues examined the association of BAR criteria with onset of BD during 10 to 13 years of follow-up. The analysis included 60 consenting people (15 to 25 years) seeking help for nonpsychotic major mental health difficulties, including mood, personality, and substance use disorders. Individuals were originally recruited from a tertiary youth mental health setting (May 1, 2008, to Sept. 30, 2010).
The researchers found that just under half of participants (28 individuals) met BAR criteria. Of those meeting BAR criteria, 28.6 percent developed BD during a mean 11.1 years of follow-up. No patients not meeting BAR criteria developed BD. The risk for developing BD was higher in the BAR group versus the non-BAR group. During follow-up, the proportions of transitions to BD were equal in the first and second halves.
"The findings suggest that those meeting BAR criteria may benefit from longer-term monitoring and support," the authors write.
Several authors disclosed financial ties to industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.